Search - tctmd.com

Displaying 901 - 920 of 4522

Sort: Relevancy | Date

Presentation TCT 2024

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

Presenter: Erwan Donal

October 27, 2024

Presentation TCT 2024

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Presenter: Gilbert Tang

October 27, 2024

Presentation TCT 2024

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

Presenter: Mirjam Wild

October 27, 2024

Presentation TCT 2024

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

Presenter: Lukas Stolz

October 27, 2024

News Opinion Editor's Corner TCT 2024

What’s Going to Be Big at TCT 2024?

Michael O'Riordan

October 17, 2024

News Conference News TCT 2023

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

Caitlin E. Cox

November 03, 2023

News Conference News TCT 2023

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Yael L. Maxwell

November 02, 2023

News Conference News TCT 2023

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

Michael O'Riordan

November 01, 2023

News Conference News TCT 2023

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

Yael L. Maxwell

October 30, 2023

News Conference News TCT 2023

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

L.A. McKeown

October 27, 2023

News Conference News TCT 2023

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

Michael O'Riordan

October 26, 2023

News Conference News TCT 2023

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Todd Neale

October 26, 2023

Presentation TCT 2023

Does Mild PVL Really Matter and What Can Be Done About It?

Presenter: Amar Krishnaswamy

October 26, 2023

News Conference News TCT 2023

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Yael L. Maxwell

October 26, 2023

Presentation TCT 2023

Always

Presenter: James McCabe

October 26, 2023

Presentation TCT 2023

Selectively

Presenter: Torsten Vahl

October 26, 2023

Presentation TCT 2023

Conduction Disturbances: Prevention and Management

Presenter: Tamim Nazif

October 26, 2023

Presentation TCT 2023

Counterpoint: The Evidence Simply Doesn’t Support Cerebral Protection, and Who’s Going to Pay for it Anyway?

Presenter: Suzanne Baron

October 26, 2023

Presentation TCT 2023

Can We Predict RV Failure After Tricuspid Intervention?

Presenter: Karl-Philipp Rommel

October 26, 2023

Presentation TCT 2023

Point: PROTECTED TAVR – The Case for CEPD

Presenter: Axel Linke

October 26, 2023

Advertisement

Multicentric Randomized Evaluation of Transcatheter Edge-to-Edge Repair for Severe Isolated Tricuspid Regurgitation: The TRI-FR Trial: Evolution Over Time of Transthoracic Echocardiography Parameters

TRILUMINATE Pivotal Trial: Outcomes in the Primary Analysis Population vs Subsequent Enrollment

Transcatheter Leaflet Repair for Tricuspid Regurgitation: 1-Year Results From the PASTE Registry

Impact of Pulmonary Hypertension on Outcomes After Transcatheter Tricuspid Valve Edge-to-Edge Repair: Insights Into the EuroTR Registry

What’s Going to Be Big at TCT 2024?

Post-TAVI Conduction Abnormalities: EP Study, Registry Data Provide Snapshots

MitraClip G4 Data Impress, but Some Question the Reproducibility: EXPAND G4

Durability, Hemodynamics Look Good for SAVR, TAVI in PARTNER 3

SUMMIT: MV Replacement With Tendyne Shows Promise in Severe MR, MAC

VIVA: No Difference Between TAVI and SAVR for Small Aortic Annuli

‘Big Step Forward’ for Transcatheter Tricuspid Valve Replacement: TRISCEND II

CLASP IID at 1 Year: Good Results With Both Pascal, MitraClip for Mitral TEER

Does Mild PVL Really Matter and What Can Be Done About It?

TRILUMINATE Deep Dive Clarifies ‘Meaningful’ QoL Gains With Tricuspid TEER

Always

Selectively

Conduction Disturbances: Prevention and Management

Counterpoint: The Evidence Simply Doesn’t Support Cerebral Protection, and Who’s Going to Pay for it Anyway?

Can We Predict RV Failure After Tricuspid Intervention?

Point: PROTECTED TAVR – The Case for CEPD

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content